Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three agents: - **Dust mite extract** is an allergen extract used primarily for allergy testing or immunotherapy, particularly in the diagnosis and management of allergic diseases such as asthma and allergic rhinitis. - **Fluticasone** is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory activity, commonly used to treat asthma, allergic rhinitis, and various inflammatory skin conditions. It acts mainly by activating the glucocorticoid receptor to suppress inflammation[2][4]. - **Methacholine** is a cholinergic agonist used almost exclusively as a diagnostic agent in bronchial challenge tests to assess airway hyperresponsiveness (e.g., for diagnosing asthma). It induces bronchoconstriction by stimulating muscarinic receptors in airway smooth muscle[7]. This combination does not represent an approved pharmaceutical product but may be encountered together in clinical research or diagnostic protocols involving allergen exposure (dust mite), anti-inflammatory treatment (fluticasone), and bronchoprovocation testing (methacholine).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dust mite extract + fluticasone + methacholine.